HuntX Pharma is a startup based in France, most recent round Seed, 2 tracked investors.
HuntX Pharma is a company founded in 2022 headquartered in France. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
HuntX Pharma develops therapies for neurological disorders, particularly those related to axonal transport defects, by creating small molecule drugs aimed at reversing the progression of conditions such as Huntington's disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.